肝素市场依产品类型、剂型及地区划分

预计到 2026 年，肝素市值将达到 75 亿美元，到 2033 年将达到 100 亿美元，2026 年至 2033 年的复合年增长率为 4.8%。

肝素是一种抗凝血剂，用于降低血液凝固能力，防止血管内形成有害血栓。它有时被称为血液稀释剂，儘管它实际上不会稀释血液。肝素不能溶解已形成的血栓，但可以防止血栓增大并引发更严重的问题。药用级肝素萃取自动物组织。肝素广泛用于治疗心臟疾病、肺动脉栓塞、深层静脉栓塞症、心房颤动，以及预防体外膜氧合（ECMO）和心肺体外迴圈期间的血栓症形成。

市场动态

心臟疾病、肺动脉栓塞和深层静脉栓塞症（ DVT）发生率的不断上升是推动市场对肝素产品需求的主要因素之一。心肌梗塞（MI）是心臟疾病的主要併发症之一。根据美国心臟协会（AHA）2018年的报告，心臟疾病是美国心血管疾病死亡的首要原因（43.8%），其次是中风（16.8%）。根据美国疾病管制与预防中心（CDC）2015年的报告，美国每年约有90万人罹患深层静脉栓塞症。

儘管肝素在慢性疾病治疗中应用广泛，但其肠道吸收率低，必须经由静脉注射或皮下注射给药。此外，其抗凝血特性会带来严重的出血风险。肝素也会诱发血小板减少性疾病（循环血小板数量减少）和超敏反应等疾病。这些因素可能会在预测期内阻碍肝素市场的发展。

本次调查的主要特点

• 本报告对肝素市场进行了详细分析，包括其市场规模以及以 2017 年为基准年，2018 年至 2026 年预测期内的复合年增长率 (%)。
• 我们重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 该报告根据以下参数对全球肝素市场的主要企业进行了分析：公司概况、财务绩效、产品系列、地理覆盖范围、分销策略、关键发展和策略。
• 本报告的研究结果将使企业负责人和经营团队能够就即将推出的产品、政府措施、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球肝素市场报告的目标受众是业内各种相关人员，包括投资者、产品製造商、经销商、肝素市场供应商、研究和咨询公司、新参与企业和金融分析师。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准情况
• PEST分析
• 波特分析
• 市场机会
• 法规环境
• 重大进展
• 产业趋势

4. 2020-2033年全球肝素市场（依产品类型划分）

• 未分级肝素（UH）
• 低分子量肝素（LMWH）
• 超低分子量肝素（ULMW）

5. 2020-2033年全球肝素市场（以剂型划分）

• 注射
• 解决方案

6. 2020-2033年全球肝素市场区域分布

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第七章 竞争情势

• Anselm Pharmaceuticals
• Baxter International Inc.
• B. Braun Melsungen AG
• Bristol-Myers Squibb Co.
• Dr. Reddy's Laboratories Ltd.
• Fresenius SE &Co. KGaA
• Leap Labchem Co.
• LEO Pharma A/S
• Pfizer, Inc.
• Sanofi SA
• Syntex SA
• Teva Pharmaceutical Industries Ltd.
• United Biotech（P）Ltd.

第八章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第九章 参考文献与调查方法

• 参考
• 调查方法
• 关于本公司

Heparin Market is estimated to be valued at USD 7,500 Mn in 2026 and is expected to reach USD 10,000 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels. It is sometimes referred as a blood thinner, although it does not actually thin the blood. Heparin does not dissolve already formed blood clots, but it can prevent the clots from becoming larger and causing more serious problems. Pharmaceutical-grade heparin is derived from animal tissue. Heparin is commonly used in the treatment of coronary heart disease, pulmonary embolism, deep vein thrombosis, and atrial fibrillation, and in the prevention of thrombosis during extracorporeal membrane oxygenation and cardiopulmonary bypass.

Market Dynamics

Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors for increased demand of heparin drugs in the market. Myocardial infarction (MI) is one of the major complications of coronary heart disease. According to the American Heart Association 2018 report, coronary heart disease is the leading cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%). As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis affects nearly 900,000 individuals in the U.S. each year.

Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine, therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions. These factors can hamper the heparin market, during the forecast period.

Key features of the study

• This report provides in-depth analysis of the heparin market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global heparin market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global heparin market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for heparin market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Unfractionated Heparin (UH)
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMW)
• Dosage Form Insights (Revenue, USD Mn, 2026 - 2033)
  • Injection
  • Solutions
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • Anselm Pharmaceuticals
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb Co.
  • Dr. Reddy's Laboratories Ltd.
  • Fresenius SE & Co. KGaA
  • Leap Labchem Co.
  • LEO Pharma A/S
  • Pfizer, Inc.
  • Sanofi S.A.
  • Syntex S.A.
  • Teva Pharmaceutical Industries Ltd.
  • United Biotech (P) Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Heparin Market, By Product Type
  • Global Heparin Market, By Dosage Form
  • Global Heparin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Heparin Market, By Product Type, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Unfractionated Heparin (UH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Low Molecular Weight Heparin (LMWH)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Ultra-low Molecular Weight Heparin (ULMW)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Heparin Market, By Dosage Form, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Heparin Market, By Region, 2020 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Anselm Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• B. Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bristol-Myers Squibb Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dr. Reddy's Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & Co. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Leap Labchem Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LEO Pharma A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Syntex S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• United Biotech (P) Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us